Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00007852 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: carmustine
DRUG: cytarabine
DRUG: etoposide
DRUG: melphalan
PROCEDURE: autologous hematopoietic stem cell transplantation

Sponsor

University of Nebraska

Collaborators

[object Object]
[object Object]